- $1.86bn
- $1.34bn
- $143.99m
- 28
- 22
- 44
- 22
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.1 | 116 | 219 | 284 | 144 |
Cost of Revenue | |||||
Gross Profit | 39.6 | 57.9 | 139 | 183 | 82.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 88.9 | 125 | 186 | 267 | 251 |
Operating Profit | -4.87 | -8.61 | 32.8 | 16.1 | -107 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.62 | -9.37 | 32.4 | 23.3 | -80.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.61 | -9.37 | 32.3 | 23.3 | -80.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.61 | -9.37 | 32.3 | 23.3 | -80.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.61 | -9.37 | 32.3 | 23.3 | -80.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.626 | -0.543 | 1.53 | 1.03 | -3.4 |